Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05HBF
|
||||
Former ID |
DNC011391
|
||||
Drug Name |
6,7-Dihydroxy-2-phenyl-chromen-4-one
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C15H10O4
|
||||
Canonical SMILES |
C1=CC=C(C=C1)C2=CC(=O)C3=CC(=C(C=C3O2)O)O
|
||||
InChI |
1S/C15H10O4/c16-11-7-14(9-4-2-1-3-5-9)19-15-8-13(18)12(17)6-10(11)15/h1-8,17-18H
|
||||
InChIKey |
GSAOUZGPXSGVRS-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Aldose reductase | Target Info | Inhibitor | [1] | |
BioCyc Pathway | Methylglyoxal degradation III | ||||
Acetone degradation I (to methylglyoxal) | |||||
KEGG Pathway | Pentose and glucuronate interconversions | ||||
Fructose and mannose metabolism | |||||
Galactose metabolism | |||||
Glycerolipid metabolism | |||||
Metabolic pathways | |||||
NetPath Pathway | IL1 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
PathWhiz Pathway | Fructose and Mannose Degradation | ||||
Pyruvate Metabolism | |||||
Pterine Biosynthesis | |||||
Glycerolipid Metabolism | |||||
Galactose Metabolism | |||||
WikiPathways | Metapathway biotransformation | ||||
Polyol Pathway | |||||
Metabolism of steroid hormones and vitamin D | |||||
References | |||||
REF 1 | J Med Chem. 1999 Jun 3;42(11):1881-93.1-Benzopyran-4-one antioxidants as aldose reductase inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.